...
首页> 外文期刊>American Family Physician >Amoxicillin/clavulanate or ibuprofen no better than placebo for acute bronchitis
【24h】

Amoxicillin/clavulanate or ibuprofen no better than placebo for acute bronchitis

机译:阿莫西林/克拉维酸盐或布洛芬对急性支气管炎的疗效优于安慰剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In adults with discolored sputum and acute bronchitis, is treatment with amoxicillin/ clavulanate (Augmentin) or ibuprofen more effective than placebo in decreasing the number of days with frequent cough? Treating acute bronchitis with amoxicillin/ clavulanate or the nonsteroidal anti-inflammatory drug ibuprofen is no more effective than placebo in decreasing symptoms in general or duration of frequent cough. Treatment does, however, produce adverse effects in one in eight patients. To quote Osier: "The desire to take medicine is perhaps the greatest feature which distinguishes man from animals." In that case, prescribing ibuprofen rather than an antibiotic may be the better way to allow patients to take medicine while their cough resolves. (Level of Evidence = 1b)
机译:在患有痰液变色和急性支气管炎的成年人中,阿莫西林/克拉维酸(奥古曼汀)或布洛芬比安慰剂在减少频繁咳嗽的天数上是否更有效?用阿莫西林/克拉维酸或非甾体类抗炎药布洛芬治疗急性支气管炎在减轻总体症状或经常咳嗽的症状方面,没有比安慰剂有效。但是,治疗确实会产生八分之一的患者不良反应。引用Osier的话:“对药物的渴望也许是区分人与动物的最大特征。”在这种情况下,开出布洛芬而不是抗生素的处方可能是让患者在咳嗽消退时服药的更好方法。 (证据水平= 1b)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号